Synthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), by Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), by Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), by End User (Hospital Pharmacies, Onl
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSynthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), by Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), by Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), by End User (Hospital Pharmacies, Onl
| Forecast Period | 2024-2028 |
| Market Size (2022) | 470.20 million |
| CAGR (2023-2028) | 12.20 % |
| Fastest Growing Segment | Online Pharmacies |
| Largest Market | North America |
Market Overview
Global Synthetic Hormones Market has valued at USD 470.20 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 12.20% through 2028. Synthetic hormones are artificially created or manufactured versions of naturally occurring hormones in the human body. These synthetic hormones have the same chemical structure and function as the hormones produced by the endocrine glands, but they are produced in laboratories rather than within the body. Synthetic hormones are used for various medical purposes, including hormone replacement therapy (HRT), contraception, and the treatment of hormone-related medical conditions. Synthetic hormones are prescribed by healthcare providers to address hormonal imbalances, manage symptoms of hormone-related conditions, and provide contraception. They are used to treat a wide range of conditions, including menopause symptoms, hypothyroidism, hormone-related cancers, and fertility control. Synthetic hormones are used in various forms of contraception, including birth control pills, patches, injections, and intrauterine devices (IUDs). These hormones prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining to make it less receptive to a fertilized egg.
Key Market Drivers
Increasing Prevalence of Hormone-Related Disorders
Hormone-related disorders encompass a wide range of conditions in which the body's natural hormonal balance is disrupted or impaired. These disorders can affect various systems and functions within the body, and they often require medical intervention. Many hormone-related disorders have become more common in recent years due to factors like lifestyle changes, environmental influences, and genetic predisposition. For example, the incidence of conditions like diabetes, thyroid disorders, and hormonal cancers has been on the rise. As the global population ages, the prevalence of age-related hormone-related disorders, such as menopause-related symptoms in women and hormonal imbalances in men, increases. Aging is a natural factor that can disrupt hormonal balance. Obesity is associated with various hormone-related disorders, including insulin resistance, polycystic ovary syndrome (PCOS), and metabolic syndrome. The global obesity epidemic has contributed to a higher incidence of these conditions. Exposure to environmental toxins, endocrine-disrupting chemicals, and other pollutants can disrupt hormonal systems, potentially leading to hormone-related disorders. Sedentary lifestyles, poor dietary habits, and increased stress levels can impact hormonal balance. These factors can contribute to the development of disorders like adrenal fatigue and insulin resistance.
Greater awareness among healthcare professionals and improved diagnostic techniques have led to earlier detection and diagnosis of hormone-related disorders. Patients are more likely to seek medical help and treatment. Many hormone-related disorders require ongoing management and treatment to alleviate symptoms, prevent complications, and improve quality of life. Synthetic hormones are often prescribed as part of these treatment regimens. For conditions like menopause and hypogonadism, hormone replacement therapy (HRT) using synthetic hormones is a standard treatment approach to relieve symptoms and restore hormonal balance. Pharmaceutical companies continue to develop and refine synthetic hormone treatments, making them more effective, safer, and easier to administer. These advancements encourage both healthcare providers and patients to opt for these therapies. Regulatory agencies, such as the FDA in the United States, have approved synthetic hormone treatments for various indications, providing a clear pathway for healthcare providers to prescribe them. This factor will help in the development of the Global Synthetic Hormones Market.
Rising Hormone Replacement Therapy (HRT)
One of the most well-known applications of HRT is in the management of menopause in women. Menopause is characterized by a decline in natural hormone levels, particularly estrogen and progesterone. HRT helps alleviate menopausal symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness, driving demand among women experiencing these symptoms. HRT is also used to treat hypogonadism, a condition characterized by insufficient production of sex hormones in both men and women. Synthetic hormones like testosterone and estrogen are prescribed to restore hormonal balance and manage related symptoms. Women who have undergone a hysterectomy (removal of the uterus) may experience hormonal imbalances. HRT can help maintain hormonal balance and prevent symptoms related to estrogen deficiency. HRT, particularly with estrogen, is sometimes used for the prevention and treatment of osteoporosis, a condition characterized by weak and brittle bones. Estrogen can help maintain bone density and reduce the risk of fractures.
Some studies suggest that HRT may have cardiovascular benefits in certain populations. Women with specific risk factors for heart disease may be prescribed HRT to help protect against heart-related issues. HRT can be tailored to individual patient needs. Healthcare providers may adjust the type, dosage, and duration of synthetic hormone therapy based on a patient's medical history, symptoms, and preferences. In cases where cancer treatment has led to hormone imbalances, HRT can be used to manage symptoms and improve the quality of life for cancer survivors. HRT is a crucial component of gender-affirming care for transgender individuals. It involves the use of synthetic hormones to align secondary sexual characteristics with gender identity. HRT can have positive effects on psychological and emotional well-being, including reducing mood swings, anxiety, and depression in individuals experiencing hormone-related imbalances. For many patients, HRT can significantly improve their overall quality of life by alleviating troublesome symptoms associated with hormone deficiencies. This factor will pace up the demand of the Global Synthetic Hormones Market.
Growing Aging Population
With age, the body's natural production of hormones, such as estrogen, progesterone, testosterone, and thyroid hormones, tends to decline. This hormonal decline can lead to a range of symptoms and health issues. Menopausal symptoms in women (e.g., hot flashes, night sweats, vaginal dryness) and andropausal symptoms in men (e.g., fatigue, decreased libido, mood changes) are often linked to age-related hormonal changes. Synthetic hormones, such as estrogen and testosterone replacement therapy, are commonly prescribed to manage these symptoms. As individuals age, they are at an increased risk of osteoporosis, a condition characterized by weakened bones. Hormone replacement therapy, particularly with estrogen, can help maintain bone density and reduce the risk of fractures. Some studies suggest that hormone replacement therapy, particularly in postmenopausal women, may have cardiovascular benefits, such as reducing the risk of heart disease. This can drive demand for synthetic hormones among older adults. Hormone therapy, including estrogen, has been explored for its potential to support cognitive function and reduce the risk of cognitive decline in older adults.
Thyroid hormone imbalances, such as hypothyroidism, become more prevalent with age. Synthetic thyroid hormones are commonly prescribed to manage these conditions. The risk of certain hormone-related cancers, such as breast and prostate cancer, increases with age. Hormone therapies, including synthetic hormones, may be part of the treatment regimen for these cancers. Many older adults seek hormone replacement therapy to improve their overall quality of life by addressing age-related symptoms and health issues. Older adults today are generally more health-conscious and aspire to lead active and fulfilling lives well into their later years. Hormone therapies can support this goal by managing age-related health challenges. As people age, they become more aware of the physical and emotional changes associated with aging and are more likely to seek medical advice and treatment options, including hormone replacement therapy. This factor will accelerate the demand of the Global Synthetic Hormones Market.
Key Market Challenges
Competition from Bioidentical Hormones
Some consumers prefer bioidentical hormones because they believe they are more "natural" and are less likely to cause adverse effects. This preference can lead to a shift in demand away from traditional synthetic hormones. Bioidentical hormones are often marketed as having fewer side effects and safety concerns compared to traditional synthetic hormones. This perception can influence patients' and healthcare providers' choices when selecting hormone replacement therapies. Bioidentical hormones are often compounded on an individual basis by compounding pharmacies to meet a patient's specific needs. This customization can make bioidentical hormones more attractive to patients seeking personalized treatment regimens. Bioidentical hormone products are sometimes marketed aggressively, highlighting their perceived benefits over traditional synthetic hormones. This marketing can sway consumer and prescriber preferences. Bioidentical hormones may face different regulatory oversight compared to synthetic hormones. In some regions, they may be classified as dietary supplements rather than pharmaceuticals, potentially leading to variations in quality and safety standards. There is an ongoing scientific debate about the safety and efficacy of bioidentical hormones compared to traditional synthetic hormones. This debate can create confusion among patients and healthcare providers. The compounding of bioidentical hormones can result in variability in the formulations and dosages of these products. This variability can make it challenging to establish consistent treatment protocols. Insurance coverage for bioidentical hormones may be less common than for traditional synthetic hormones, leading to higher out-of-pocket costs for patients. Bioidentical hormones may not have as extensive a body of clinical research and data supporting their safety and efficacy as traditional synthetic hormones. This can affect prescriber confidence in their use.
Patent Expirations
Once a patent expires, generic drug manufacturers can produce and market generic versions of the formerly patented synthetic hormone drug. Generic competition typically leads to lower drug prices, which can reduce the market share and profitability of the brand-name synthetic hormone. With the entry of generic competitors, prices for the synthetic hormone drug can decline significantly. This can impact the revenue generated by the drug, especially for the original manufacturer. As generic versions become found at, they may gain a substantial share of the market, especially if they are priced significantly lower than the brand-name drug. This can lead to a reduced market share for the original drug. Patent expirations often result in a decline in the revenue generated by the brand-name synthetic hormone drug. This can impact the financial health of the pharmaceutical company that developed and marketed the drug. The entry of generic competitors can intensify competition within the market. Pharmaceutical companies may need to invest more in marketing and promotion to maintain market share. Before patent expiration, the original manufacturer of the synthetic hormone drug typically holds a monopoly on its sale. After patent expiration, multiple manufacturers can produce the drug, reducing the original company's exclusive control over the market. The influx of generic versions of the synthetic hormone drug can saturate the market, making it more challenging for all manufacturers to maintain profitability.
Key Market Trends
Focus on Personalized Medicine
Personalized medicine allows healthcare providers to select the most appropriate synthetic hormone therapy and dosage for each patient based on their specific hormonal imbalances, genetics, and response to treatment. This can lead to more effective and efficient treatment outcomes. By considering individual patient factors, including genetic variations and susceptibility to side effects, personalized medicine aims to minimize adverse reactions to synthetic hormones, improving patient safety and compliance. For conditions such as menopause or hypogonadism, personalized medicine enables the customization of hormone replacement therapy (HRT) to meet the unique needs of each patient. This can result in more precise symptom relief and hormonal balance. Personalized medicine may involve genetic testing to identify individuals at higher risk for hormone-related disorders or cancers. Such insights can lead to early intervention and prevention strategies. Continuous monitoring of patients' response to synthetic hormone therapies, including hormonal levels and symptom improvement, allows for real-time adjustments to treatment plans, ensuring optimal outcomes. Genetic testing and the identification of biomarkers can help identify patients who are most likely to benefit from specific synthetic hormone treatments, improving the cost-effectiveness of therapies. In the context of hormone-related cancers (e.g., breast, prostate), personalized medicine can guide treatment decisions, including the use of hormone therapies and targeted therapies tailored to the individual's cancer genetics. Personalized medicine aims to reduce overtreatment by avoiding unnecessary hormonal interventions for individuals who do not require them, thus minimizing potential risks and costs.
Segmental Insights
Type Insights
In 2022, the Global Synthetic Hormones Market largest share was held by Steroid Hormones segment and is predicted to continue expanding over the coming years.
Route of Administration Insights
In 2022, the Global Synthetic Hormones Market largest share was held by Oral segment and is predicted to continue expanding over the coming years.
Application Insights
In 2022, the Global Synthetic Hormones Market largest share was held by Male Hypogonadism segment and is predicted to continue expanding over the coming years.
End-User Insights
In 2022, the Global Synthetic Hormones Market largest share was held by
Regional Insights
The North America region dominates the Global Synthetic Hormones Market in 2022.
Recent Developments
- In February 2022, The European Commission has approvedthe once-weekly injection of NGENLA (somatrogon), a next-generation long-actingrecombinant human growth hormone, to treat children and adolescents from theage of three who have growth disturbances caused by insufficient growth hormonesecretion. NGENLA offers paediatric kids with growth hormone deficiency (GHD),their carers, and healthcare professionals a novel therapy option that lowersthe frequency of necessary injections from once daily to once weekly. NGENLA (somatrogon)is a synthetic growth hormone that works by replacing the lack of growthhormone in the body. NGENLA is taken by injection just below the skin. Comparedto the growth hormone GENOTROPIN (somatropin), its action in the body lastslonger, enabling weekly injections instead of daily. GHD is a rare disease characterized by theinadequate secretion of the growth hormone, somatropin, from the pituitarygland and affects one in approximately 4,000 to 10,000 children worldwide. Thedisease can be caused by genetic mutations or acquired after birth. Withouttreatment, affected children will have persistent growth attenuation and a veryshort height in adulthood, and puberty may be delayed. Children may alsoexperience other problems with physical health and mental well-being.
- In October 2021, Theramex has launched Bijuva / Bijuveacross Europe and the UK. Bijuva, (known as Bijuve in the UK), is the first,and only, body-identical hormone therapy treatment (HRT) for estrogendeficiency symptoms in post-menopausal women with intact uterus and at least 12months since last menses, which combines estradiol and progesterone in a singledaily oral capsule. Unlike synthetic hormone products, the estradiol andprogesterone found in Bijuva / Bijuve are chemically and biologically identicalto the hormones naturally circulating in the woman’s body. The idea of usingbody identical hormones to replace estrogens and to protect the endometriumwith progesterone appeals to many women. These hormones that many women preferare now available in a combined single capsule that has been shown to beeffective and well-tolerated.
Key Market Players
- Acerus Pharmaceuticals Corp.
- American Regent, Inc.
- Anhui Anke Biotechnology (Group) Co. Ltd.
- BioPartners, Inc
- Eli Lilly and Company
- Endo Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- IBSA Institut Biochimique SA
- Lupin Pharmaceuticals, Inc.
- Pfizer, Inc
| By Product | By Route of Administration | By Application | By End-User | By Region |
|
|
|
|
|
Report Scope
In this report, the Global Synthetic Hormones Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below
- Synthetic Hormones Market, By Product
o
o
o
- Synthetic Hormones Market, By Route of Administration
o
o
o
o
o
- Synthetic Hormones Market, By Application
o
o
o
o
- Synthetic Hormones Market, By End-User
o
o
o
- Global Synthetic Hormones Market, By region
North America
Asia-Pacific
Europe
South America
Middle East & Africa
Competitive Landscape
Company Profiles
found at Customizations
Company Information
- Detailed analysis and profiling of additional market players (up to five).
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy